Quick summary
Carnosine is a natural dipeptide (beta-alanine + L-histidine) in muscle and brain that acts as an antioxidant, pH buffer, metal chelator, and anti-glycation agent. It delays cellular senescence in fibroblasts and extends lifespan in animal models.
Overview
Carnosine is a naturally occurring dipeptide (beta-alanine + L-histidine) found in high concentrations in skeletal muscle and brain tissue — long-lived, high-energy-demand tissues. It functions as an endogenous antioxidant, pH buffer, metal chelator, and anti-glycation agent. Carnosine has attracted significant interest in geroscience for its apparent ability to delay cellular senescence in human fibroblasts and extend lifespan in animal models.
Mechanism of action
Carnosine exerts its biological effects through multiple complementary pathways. As an antioxidant, it scavenges reactive oxygen and nitrogen species and inhibits lipid peroxidation. As a metal chelator, it sequesters pro-oxidant transition metal ions such as copper and zinc. As an anti-glycation agent, it reacts with reactive carbonyl compounds to prevent advanced glycation end product (AGE) formation. Carnosine also buffers intracellular pH during anaerobic exercise, protects mitochondrial function, and may upregulate stress protein expression and proteasomal activity to clear damaged proteins — a mechanism relevant to cellular aging.
Dosing protocols
| Purpose | Route | Dosage | Frequency | Notes |
|---|---|---|---|---|
| antioxidant / anti-aging | oral | 500–1000 mg | once or twice daily | Often taken with meals. Some protocols use 1000 mg twice daily for therapeutic intent. |
Dosing information is for educational purposes only. Consult a qualified healthcare professional before using any peptide.
Research summary
Preclinical studies show carnosine suppresses cultured human fibroblast senescence and delays aging in senescence-accelerated mice and Drosophila. Animal studies confirm improved antioxidant status in liver, heart, and brain. Human studies primarily focus on exercise performance and carnosine's role as a pH buffer in muscle. Neurodegenerative disease applications are under active preclinical investigation as of 2025. Long-term human longevity data are lacking.[1][2][3][4][5]
Evidence grading
Each claimed benefit is graded by the strength of available evidence. Grades reflect study quality, not effect size.
Strong = multiple RCTs · Moderate = limited trials or observational · Preliminary = animal or in vitro only · Insufficient = anecdotal or no published data
Side effects
Side effects vary by individual. This is not an exhaustive list. Report unusual symptoms to a healthcare professional.
Common stacks
Peptides commonly paired with Carnosine for synergistic effects.
Legal status
Widely available OTC dietary supplement. Not regulated as a drug. Available in capsule, powder, and eye-drop formulations globally.
Sourcing & access
Research compound
Carnosine is classified as a research compound. Regulatory status varies by jurisdiction. Always verify current legal status and source from vendors providing third-party certificates of analysis (COA).
Frequently asked questions
Carnosine (L-Carnosine) is a naturally occurring dipeptide of beta-alanine and L-histidine found in high concentrations in skeletal muscle and brain tissue — both long-lived, high-energy-demand tissues. It functions simultaneously as an antioxidant, intracellular pH buffer, metal chelator, and anti-glycation agent. Available as an OTC dietary supplement, it has attracted significant interest in geroscience for its apparent ability to delay cellular senescence.
Carnosine acts through multiple complementary pathways: it scavenges reactive oxygen and nitrogen species, chelates pro-oxidant transition metals such as copper and zinc, reacts with reactive carbonyl compounds to prevent advanced glycation end product (AGE) formation, buffers intracellular pH during anaerobic exercise, protects mitochondrial function, and may upregulate proteasomal activity to clear damaged proteins — a mechanism directly relevant to cellular aging.
Carnosine is generally well tolerated at commonly used doses of 500 to 1000 mg once or twice daily. Rare side effects include nausea and mild tingling. It is rapidly hydrolyzed by the enzyme carnosinase in plasma, giving it a half-life of approximately 2 to 3 hours. This rapid clearance means it accumulates primarily within tissues rather than systemically, which may contribute to its favorable safety profile.
Preclinical studies show carnosine suppresses replicative senescence in cultured human fibroblasts and delays aging phenotypes in senescence-accelerated mice and Drosophila models. Animal studies confirm improved antioxidant status in liver, heart, and brain tissue. However, robust long-term human longevity data are lacking; most human evidence focuses on exercise performance and buffering capacity rather than aging outcomes directly.
Research references
- Carnosine as a Natural Antioxidant and Geroprotector: From Molecular Mechanisms to Clinical TrialsPubMed
- Carnosine and Related Peptides: Therapeutic Potential in Age-Related DisordersPubMed
- Antioxidant and Neuroprotective Effects of Carnosine: Therapeutic Implications in Neurodegenerative DiseasesPubMed
- The Therapeutic Potential of Carnosine/Anserine Supplementation against Cognitive Decline: A Systematic Review with Meta-AnalysisPubMed
- Carnosine Improves Aging-Induced Cognitive Impairment and Brain Regional Neurodegeneration in Relation to the Neuropathological Alterations in the Secondary Structure of Amyloid Beta (Aβ)PubMed